The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global mRNA Vaccines & Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global mRNA Vaccines & Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028

Publishing Date : Feb, 2022

License Type :
 

Report Code : 1456440

No of Pages : 107

Synopsis
The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global mRNA Vaccines & Therapeutics market size is estimated to be worth US$ 37740 million in 2021 and is forecast to a readjusted size of USD 13790 million by 2028 with a CAGR of -13.4% during review period. Infectious Disease accounting for % of the mRNA Vaccines & Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Infectious Disease Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of mRNA Vaccines & Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, and Sangamo Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Infectious Disease Vaccines
Cancer Vaccines
Market segment by Application can be divided into
Infectious Disease
Cancer
The key market players for global mRNA Vaccines & Therapeutics market are listed below:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales, revenue and global market share of mRNA Vaccines & Therapeutics from 2019 to 2022.
Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Vaccines & Therapeutics.
Chapter 13, 14, and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Geographical Area
Global
Index
1 Market Overview
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Global mRNA Vaccines & Therapeutics Market Size & Forecast
1.4.1 Global mRNA Vaccines & Therapeutics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global mRNA Vaccines & Therapeutics Sales in Volume (2017-2028)
1.4.3 Global mRNA Vaccines & Therapeutics Price (2017-2028)
1.5 Global mRNA Vaccines & Therapeutics Production Capacity Analysis
1.5.1 Global mRNA Vaccines & Therapeutics Total Production Capacity (2017-2028)
1.5.2 Global mRNA Vaccines & Therapeutics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 mRNA Vaccines & Therapeutics Market Drivers
1.6.2 mRNA Vaccines & Therapeutics Market Restraints
1.6.3 mRNA Vaccines & Therapeutics Trends Analysis
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
2.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Vaccines & Therapeutics Product and Services
2.2.4 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio mRNA Vaccines & Therapeutics Product and Services
2.3.4 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Vaccines & Therapeutics Product and Services
2.4.4 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
2.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
2.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
2.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA mRNA Vaccines & Therapeutics Product and Services
2.8.4 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Vaccines & Therapeutics Product and Services
2.9.4 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
2.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 mRNA Vaccines & Therapeutics Breakdown Data by Manufacturer
3.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in mRNA Vaccines & Therapeutics
3.4 Market Concentration Rate
3.4.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2021
3.4.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2021
3.5 Global mRNA Vaccines & Therapeutics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and mRNA Vaccines & Therapeutics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global mRNA Vaccines & Therapeutics Market Size by Region
4.1.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Region (2017-2028)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Region (2017-2028)
4.2 North America mRNA Vaccines & Therapeutics Revenue (2017-2028)
4.3 Europe mRNA Vaccines & Therapeutics Revenue (2017-2028)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Revenue (2017-2028)
4.5 South America mRNA Vaccines & Therapeutics Revenue (2017-2028)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Type (2017-2028)
5.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
5.3 Global mRNA Vaccines & Therapeutics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Application (2017-2028)
6.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
6.3 Global mRNA Vaccines & Therapeutics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
7.2 North America mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
7.3 North America mRNA Vaccines & Therapeutics Market Size by Country
7.3.1 North America mRNA Vaccines & Therapeutics Sales in Volume by Country (2017-2028)
7.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
8.2 Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
8.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
8.3.1 Europe mRNA Vaccines & Therapeutics Sales in Volume by Country (2017-2028)
8.3.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
9.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
9.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
10.2 South America mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
10.3 South America mRNA Vaccines & Therapeutics Market Size by Country
10.3.1 South America mRNA Vaccines & Therapeutics Sales in Volume by Country (2017-2028)
10.3.2 South America mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
11.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
11.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of mRNA Vaccines & Therapeutics and Key Manufacturers
12.2 Manufacturing Costs Percentage of mRNA Vaccines & Therapeutics
12.3 mRNA Vaccines & Therapeutics Production Process
12.4 mRNA Vaccines & Therapeutics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 mRNA Vaccines & Therapeutics Typical Distributors
13.3 mRNA Vaccines & Therapeutics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
List of Tables
Table 1. Global mRNA Vaccines & Therapeutics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global mRNA Vaccines & Therapeutics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Moderna Therapeutics Major Business
Table 5. Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 6. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CureVac Basic Information, Manufacturing Base and Competitors
Table 8. CureVac Major Business
Table 9. CureVac mRNA Vaccines & Therapeutics Product and Services
Table 10. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 12. Translate Bio Major Business
Table 13. Translate Bio mRNA Vaccines & Therapeutics Product and Services
Table 14. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BioNTech Basic Information, Manufacturing Base and Competitors
Table 16. BioNTech Major Business
Table 17. BioNTech mRNA Vaccines & Therapeutics Product and Services
Table 18. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Sangamo Therapeutics Major Business
Table 21. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 22. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Argos Therapeutics Major Business
Table 25. Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 26. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 28. In-Cell-Art Major Business
Table 29. In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
Table 30. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 32. eTheRNA Major Business
Table 33. eTheRNA mRNA Vaccines & Therapeutics Product and Services
Table 34. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Ethris Basic Information, Manufacturing Base and Competitors
Table 36. Ethris Major Business
Table 37. Ethris mRNA Vaccines & Therapeutics Product and Services
Table 38. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 40. Tiba Biotechnology Major Business
Table 41. Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
Table 42. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 44. Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in mRNA Vaccines & Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global mRNA Vaccines & Therapeutics Production Capacity by Company, (M Doses): 2020 VS 2021
Table 47. Head Office and mRNA Vaccines & Therapeutics Production Site of Key Manufacturer
Table 48. mRNA Vaccines & Therapeutics New Entrant and Capacity Expansion Plans
Table 49. mRNA Vaccines & Therapeutics Mergers & Acquisitions in the Past Five Years
Table 50. Global mRNA Vaccines & Therapeutics Sales by Region (2017-2022) & (M Doses)
Table 51. Global mRNA Vaccines & Therapeutics Sales by Region (2023-2028) & (M Doses)
Table 52. Global mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 53. Global mRNA Vaccines & Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 54. Global mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 55. Global mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 56. Global mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 57. Global mRNA Vaccines & Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 58. Global mRNA Vaccines & Therapeutics Price by Type (2017-2022) & (USD/Doses)
Table 59. Global mRNA Vaccines & Therapeutics Price by Type (2023-2028) & (USD/Doses)
Table 60. Global mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 61. Global mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 62. Global mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 63. Global mRNA Vaccines & Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 64. Global mRNA Vaccines & Therapeutics Price by Application (2017-2022) & (USD/Doses)
Table 65. Global mRNA Vaccines & Therapeutics Price by Application (2023-2028) & (USD/Doses)
Table 66. North America mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
Table 67. North America mRNA Vaccines & Therapeutics Sales by Country (2023-2028) & (M Doses)
Table 68. North America mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 69. North America mRNA Vaccines & Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 70. North America mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 71. North America mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 72. North America mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 73. North America mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 74. Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
Table 75. Europe mRNA Vaccines & Therapeutics Sales by Country (2023-2028) & (M Doses)
Table 76. Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe mRNA Vaccines & Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 79. Europe mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 80. Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 81. Europe mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 82. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2017-2022) & (M Doses)
Table 83. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2023-2028) & (M Doses)
Table 84. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 87. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 88. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 89. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 90. South America mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
Table 91. South America mRNA Vaccines & Therapeutics Sales by Country (2023-2028) & (M Doses)
Table 92. South America mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 93. South America mRNA Vaccines & Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 94. South America mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 95. South America mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 96. South America mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 97. South America mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 98. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Region (2017-2022) & (M Doses)
Table 99. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Region (2023-2028) & (M Doses)
Table 100. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
Table 103. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2023-2028) & (M Doses)
Table 104. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
Table 105. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2023-2028) & (M Doses)
Table 106. mRNA Vaccines & Therapeutics Raw Material
Table 107. Key Manufacturers of mRNA Vaccines & Therapeutics Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. mRNA Vaccines & Therapeutics Typical Distributors
Table 111. mRNA Vaccines & Therapeutics Typical Customers
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Picture
Figure 2. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type in 2021
Figure 3. Infectious Disease Vaccines
Figure 4. Cancer Vaccines
Figure 5. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2021
Figure 6. Infectious Disease
Figure 7. Cancer
Figure 8. Global mRNA Vaccines & Therapeutics Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 9. Global mRNA Vaccines & Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global mRNA Vaccines & Therapeutics Sales (2017-2028) & (M Doses)
Figure 11. Global mRNA Vaccines & Therapeutics Price (2017-2028) & (USD/Doses)
Figure 12. Global mRNA Vaccines & Therapeutics Production Capacity (2017-2028) & (M Doses)
Figure 13. Global mRNA Vaccines & Therapeutics Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. mRNA Vaccines & Therapeutics Market Drivers
Figure 15. mRNA Vaccines & Therapeutics Market Restraints
Figure 16. mRNA Vaccines & Therapeutics Market Trends
Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2021
Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2021
Figure 19. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2021
Figure 22. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2028)
Figure 23. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2017-2028)
Figure 24. North America mRNA Vaccines & Therapeutics Revenue (2017-2028) & (USD Million)
Figure 25. Europe mRNA Vaccines & Therapeutics Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific mRNA Vaccines & Therapeutics Revenue (2017-2028) & (USD Million)
Figure 27. South America mRNA Vaccines & Therapeutics Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa mRNA Vaccines & Therapeutics Revenue (2017-2028) & (USD Million)
Figure 29. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 30. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
Figure 31. Global mRNA Vaccines & Therapeutics Price by Type (2017-2028) & (USD/Doses)
Figure 32. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 33. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
Figure 34. Global mRNA Vaccines & Therapeutics Price by Application (2017-2028) & (USD/Doses)
Figure 35. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 36. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 37. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2028)
Figure 38. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2028)
Figure 39. United States mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 43. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 44. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2028)
Figure 45. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2028)
Figure 46. Germany mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region (2017-2028)
Figure 55. China mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 62. South America mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 63. South America mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2028)
Figure 64. South America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2028)
Figure 65. Brazil mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Region (2017-2028)
Figure 71. Turkey mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics in 2021
Figure 76. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure 77. mRNA Vaccines & Therapeutics Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

Published By : GlobalInfoResearch

Why ‘The Market Reports’